Share your videos with the world

Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols. When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.” To view the multimedia release go to: https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/

As the cold and flu season peaks, adults may take multiple over-the-counter (OTC) pain medicines to treat their pain and fever symptoms. Yet many are unaware of the serious liver or gastrointestinal damage that can result from the overdose or overuse of common OTC pain medicine ingredients. To help adults safely take these medicines, the American Gastroenterological Association (AGA) today launched Gut Check: Know Your Medicine, an education campaign focused on the safe use of OTC products. Central to the campaign is a unique flipbook-style video that highlights the importance of reading and following OTC medicine labels. To view the Multimedia News Release, go to http://www.multivu.com/mnr/65680-american-gastroenterological-aga-gut-check-know-your-medicine-otc-psa

Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that the European Commission has granted marketing authorization to Constella® (linaclotide 290mcg) for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation (IBS-C) in adults . This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use (CHMP) in September. To view Multimedia News Release, go to http://www.multivu.com/mnr/58658-almirall